ID   PM34_HUMAN              Reviewed;         307 AA.
AC   O43808; A8KA59; Q5TFL0; Q9UGW8; Q9UGY7;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   15-MAR-2017, entry version 149.
DE   RecName: Full=Peroxisomal membrane protein PMP34;
DE   AltName: Full=34 kDa peroxisomal membrane protein;
DE   AltName: Full=Solute carrier family 25 member 17;
GN   Name=SLC25A17; Synonyms=PMP34;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=9874197; DOI=10.1046/j.1432-1327.1998.2580332.x;
RA   Wylin T., Baes M., Brees C., Mannaerts G.P., Fransen M.,
RA   Van Veldhoven P.P.;
RT   "Identification and characterization of human PMP34, a protein closely
RT   related to the peroxisomal integral membrane protein PMP47 of Candida
RT   boidinii.";
RL   Eur. J. Biochem. 258:332-338(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH PEX19.
RX   PubMed=10704444; DOI=10.1083/jcb.148.5.931;
RA   Sacksteder K.A., Jones J.M., South S.T., Li X., Liu Y., Gould S.J.;
RT   "PEX19 binds multiple peroxisomal membrane proteins, is predominantly
RT   cytoplasmic, and is required for peroxisome membrane synthesis.";
RL   J. Cell Biol. 148:931-944(2000).
RN   [8]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND MUTAGENESIS OF 190-LYS--LYS-199.
RX   PubMed=11121399; DOI=10.1074/jbc.M003304200;
RA   Honsho M., Fujiki Y.;
RT   "Topogenesis of peroxisomal membrane protein requires a short,
RT   positively charged intervening-loop sequence and flanking hydrophobic
RT   segments: study using human membrane protein PMP34.";
RL   J. Biol. Chem. 276:9375-9382(2001).
RN   [9]
RP   INTERACTION WITH PEX19, TOPOLOGY, SUBCELLULAR LOCATION, AND
RP   PEROXISOMAL TARGETING.
RX   PubMed=11402059; DOI=10.1083/jcb.153.6.1141;
RA   Jones J.M., Morrell J.C., Gould S.J.;
RT   "Multiple distinct targeting signals in integral peroxisomal membrane
RT   proteins.";
RL   J. Cell Biol. 153:1141-1150(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=12445829; DOI=10.1016/S0006-291X(02)02663-3;
RA   Visser W.F., van Roermund C.W., Waterham H.R., Wanders R.J.;
RT   "Identification of human PMP34 as a peroxisomal ATP transporter.";
RL   Biochem. Biophys. Res. Commun. 299:494-497(2002).
RN   [11]
RP   INTERACTION WITH PEX19, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   283-LEU--PHE-285; 289-GLU-LYS-290 AND 302-LYS-GLU-303.
RX   PubMed=14709540; DOI=10.1083/jcb.200304111;
RA   Jones J.M., Morrell J.C., Gould S.J.;
RT   "PEX19 is a predominantly cytosolic chaperone and import receptor for
RT   class 1 peroxisomal membrane proteins.";
RL   J. Cell Biol. 164:57-67(2004).
RN   [12]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=22185573; DOI=10.1042/BJ20111420;
RA   Agrimi G., Russo A., Scarcia P., Palmieri F.;
RT   "The human gene SLC25A17 encodes a peroxisomal transporter of coenzyme
RT   A, FAD and NAD+.";
RL   Biochem. J. 443:241-247(2012).
CC   -!- FUNCTION: Peroxisomal transporter for multiple cofactors like
CC       coenzyme A (CoA), flavin adenine dinucleotide (FAD), flavin
CC       mononucleotide (FMN) and nucleotide adenosine monophosphate (AMP),
CC       and to a lesser extent for nicotinamide adenine dinucleotide
CC       (NAD(+)), adenosine diphosphate (ADP) and adenosine 3',5'-
CC       diphosphate (PAP). May catalyze the transport of free CoA, FAD and
CC       NAD(+) from the cytosol into the peroxisomal matrix by a counter-
CC       exchange mechanism. Inhibited by pyridoxal 5'-phosphate and
CC       bathophenanthroline in vitro. {ECO:0000269|PubMed:12445829,
CC       ECO:0000269|PubMed:22185573}.
CC   -!- SUBUNIT: Interacts (via N- and C-terminus peroxisomal targeting
CC       regions) with PEX19; the interaction occurs with the newly
CC       synthesized SLC25A17 in the cytosol. {ECO:0000269|PubMed:10704444,
CC       ECO:0000269|PubMed:11402059, ECO:0000269|PubMed:14709540}.
CC   -!- INTERACTION:
CC       P40855:PEX19; NbExp=4; IntAct=EBI-594912, EBI-594747;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Peroxisome membrane; Multi-pass
CC       membrane protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Expressed in liver.
CC       {ECO:0000269|PubMed:22185573}.
CC   -!- DOMAIN: The N- and C-terminal portions are exposed to the
CC       cytoplasm. Lacks a typical peroxisomal sorting signal. A region
CC       between helical transmembrane domains (TM) 4 and 5 and TM1-TM3 or
CC       TM4-TM6 are necessary for the peroxisome-targeting activity.
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29)
CC       family. {ECO:0000305}.
CC   -!- CAUTION: Was first identified as a peroxisomal ATP transporter
CC       (PubMed:12445829). However, later experiments showed that it acts
CC       as a peroxisomal transporter for multiple cofactors
CC       (PubMed:22185573). {ECO:0000305|PubMed:12445829,
CC       ECO:0000305|PubMed:22185573}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y12860; CAA73367.1; -; mRNA.
DR   EMBL; CR456577; CAG30463.1; -; mRNA.
DR   EMBL; AK292924; BAF85613.1; -; mRNA.
DR   EMBL; AL049764; CAI20333.1; -; Genomic_DNA.
DR   EMBL; Z98048; CAI20333.1; JOINED; Genomic_DNA.
DR   EMBL; Z98048; CAI20491.1; -; Genomic_DNA.
DR   EMBL; AL049764; CAI20491.1; JOINED; Genomic_DNA.
DR   EMBL; CH471095; EAW60390.1; -; Genomic_DNA.
DR   EMBL; BC005957; AAH05957.1; -; mRNA.
DR   EMBL; BC012998; AAH12998.1; -; mRNA.
DR   CCDS; CCDS14005.1; -.
DR   RefSeq; NP_001269656.1; NM_001282727.1.
DR   RefSeq; NP_006349.1; NM_006358.3.
DR   UniGene; Hs.474938; -.
DR   ProteinModelPortal; O43808; -.
DR   BioGrid; 115741; 30.
DR   IntAct; O43808; 3.
DR   STRING; 9606.ENSP00000390722; -.
DR   TCDB; 2.A.29.20.1; the mitochondrial carrier (mc) family.
DR   iPTMnet; O43808; -.
DR   PhosphoSitePlus; O43808; -.
DR   EPD; O43808; -.
DR   MaxQB; O43808; -.
DR   PaxDb; O43808; -.
DR   PeptideAtlas; O43808; -.
DR   PRIDE; O43808; -.
DR   DNASU; 10478; -.
DR   Ensembl; ENST00000435456; ENSP00000390722; ENSG00000100372.
DR   GeneID; 10478; -.
DR   KEGG; hsa:10478; -.
DR   UCSC; uc003azc.5; human.
DR   CTD; 10478; -.
DR   GeneCards; SLC25A17; -.
DR   HGNC; HGNC:10987; SLC25A17.
DR   HPA; HPA052708; -.
DR   HPA; HPA060972; -.
DR   MIM; 606795; gene.
DR   neXtProt; NX_O43808; -.
DR   OpenTargets; ENSG00000100372; -.
DR   PharmGKB; PA35863; -.
DR   eggNOG; KOG0769; Eukaryota.
DR   eggNOG; ENOG410ZNC0; LUCA.
DR   GeneTree; ENSGT00770000120566; -.
DR   HOGENOM; HOG000159426; -.
DR   HOVERGEN; HBG003235; -.
DR   InParanoid; O43808; -.
DR   KO; K13354; -.
DR   OMA; MGLKSAH; -.
DR   OrthoDB; EOG091G0DMQ; -.
DR   PhylomeDB; O43808; -.
DR   TreeFam; TF324772; -.
DR   Reactome; R-HSA-389599; Alpha-oxidation of phytanate.
DR   GeneWiki; SLC25A17; -.
DR   GenomeRNAi; 10478; -.
DR   PRO; PR:O43808; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100372; -.
DR   CleanEx; HS_SLC25A17; -.
DR   ExpressionAtlas; O43808; baseline and differential.
DR   Genevisible; O43808; HS.
DR   GO; GO:0005779; C:integral component of peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:BHF-UCL.
DR   GO; GO:0000295; F:adenine nucleotide transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015217; F:ADP transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0080122; F:AMP transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005347; F:ATP transmembrane transporter activity; IGI:BHF-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0015228; F:coenzyme A transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015230; F:FAD transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0044610; F:FMN transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0051724; F:NAD transporter activity; IDA:UniProtKB.
DR   GO; GO:0015867; P:ATP transport; IGI:BHF-UCL.
DR   GO; GO:0001561; P:fatty acid alpha-oxidation; TAS:Reactome.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IGI:BHF-UCL.
DR   GO; GO:0015908; P:fatty acid transport; IGI:BHF-UCL.
DR   GO; GO:0006839; P:mitochondrial transport; IBA:GO_Central.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR002067; Mit_carrier.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom.
DR   Pfam; PF00153; Mito_carr; 3.
DR   PRINTS; PR00926; MITOCARRIER.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Membrane; Peroxisome; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    307       Peroxisomal membrane protein PMP34.
FT                                /FTId=PRO_0000090705.
FT   TOPO_DOM      1      9       Cytoplasmic.
FT   TRANSMEM     10     30       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     31     66       Lumenal. {ECO:0000255}.
FT   TRANSMEM     67     87       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM     88    104       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    105    125       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    126    160       Lumenal. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    182    202       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    203    223       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    224    280       Lumenal. {ECO:0000255}.
FT   TRANSMEM    281    301       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    302    307       Cytoplasmic.
FT   REPEAT        7     92       Solcar 1.
FT   REPEAT       99    192       Solcar 2.
FT   REPEAT      200    294       Solcar 3.
FT   REGION        1    147       Necessary for targeting to peroxisomes
FT                                and interaction with PEX19.
FT   REGION      244    307       Necessary for targeting to peroxisomes
FT                                and interaction with PEX19.
FT   MOTIF       190    199       Peroxisome localization signal.
FT   VARIANT      98     98       H -> R (in dbSNP:rs12159334).
FT                                /FTId=VAR_050139.
FT   MUTAGEN     190    199       KRQLLKKRMK->AAQLLAAAMA: Localizes in the
FT                                cytoplasm. {ECO:0000269|PubMed:11121399}.
FT   MUTAGEN     283    285       LMF->KKK: Impairs interaction with PEX19.
FT                                {ECO:0000269|PubMed:14709540}.
FT   MUTAGEN     289    290       EK->LL: Impairs interaction with PEX19.
FT                                {ECO:0000269|PubMed:14709540}.
FT   MUTAGEN     302    303       KR->EE: No effect on interaction with
FT                                PEX19. {ECO:0000269|PubMed:14709540}.
SQ   SEQUENCE   307 AA;  34567 MW;  B7043D82966D47A5 CRC64;
     MASVLSYESL VHAVAGAVGS VTAMTVFFPL DTARLRLQVD EKRKSKTTHM VLLEIIKEEG
     LLAPYRGWFP VISSLCCSNF VYFYTFNSLK ALWVKGQHST TGKDLVVGFV AGVVNVLLTT
     PLWVVNTRLK LQGAKFRNED IVPTNYKGII DAFHQIIRDE GISALWNGTF PSLLLVFNPA
     IQFMFYEGLK RQLLKKRMKL SSLDVFIIGA VAKAIATTVT YPLQTVQSIL RFGRHRLNPE
     NRTLGSLRNI LYLLHQRVRR FGIMGLYKGL EAKLLQTVLT AALMFLVYEK LTAATFTVMG
     LKRAHQH
//
